Meno Supremacy
Natural health product licensed in Canada
- Other names
- Pro Meno
- Licence holder
- TriStar Naturals
- NPN or DIN-HM
- 80030569
- Status
- Inactive licence
- Licence date
- 16 March 2012
- Revision date
- 22 February 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Angelica sinensis Source : Racine Extraction ratio : 7:1 Dry plant equivalent : 350 mg | 50 mg | Not calculated |
| Gamma-oryzanol Source : Seed Bran | 150 mg | Not calculated |
| Gamma-oryzanol Source : Oryza sativa | 150 mg | Not calculated |
| Gamma-oryzanol Source : Gamma-oryzanol | 150 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the pain associated with menstruation. Used in Herbal Medicine to help relieve premenstrual symptoms. Used in Herbal Medicine to help relieve symptoms associated with menopause. Used in Herbal Medicine to help ease nervous tension (calmative). Used in Herbal Medicine to help relieve muscle and joint pain associated with rheumatic conditions (such as rheumatoid arthritis, osteoarthritis and/or fibrositis), and of pain associated with neuralgia (such as sciatica).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80030569
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging